Gossamer Bio GOSS
NASDAQ GOSS
$9.46 -0.33 (-3.37%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Long-Term Debt Repayments (2018 - 2024)

Updated

Gossamer Bio (GOSS) reported Long-Term Debt Repayments of $12.58 million for FY2024, up 8.3% from $11.61 million in FY2023.

Analysis

Gossamer Bio (GOSS) Long-Term Debt Repayments (2018 - 2024) Analysis & Trends

Dating back to FY2018, Gossamer Bio's Long-Term Debt Repayments record includes 4 years.

  • According to Business Quant data, Long-Term Debt Repayments came in at $11.61 million in FY2023 (+100.0%) and $5.81 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 1.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 2.00 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 2.46 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Gossamer Bio 37.12 Mn -436.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 9.68 Mn
Mar 31, 2024 2.90 Mn
Dec 31, 2023 2.90 Mn
Sep 30, 2023 2.90 Mn
Jun 30, 2023 2.90 Mn
Mar 31, 2023 2.90 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 2.90 Mn
Mar 31, 2018 40,000.00
API Access

Gossamer Bio Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=GOSS&period=max&api_key=YOUR_API_KEY